We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLBC:NASDAQPlumas Bancorp Analysis

Data as of 2026-05-23 - not real-time

$52.66

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

PLBC is exhibiting a clear bullish technical setup as its price sits above the short‑term moving average while still remaining under the long‑term trend line. The 20‑day SMA sits above the 50‑day SMA, indicating upward momentum. Momentum indicators are positive, with the MACD line above its signal and a histogram that is expanding. The RSI is comfortably in the upper‑mid range, supporting the bullish bias without being overbought. Trading volume has been on an upward trajectory, reinforcing the strength of recent price gains. Insider activity has turned positive, with multiple insiders adding to their positions, a signal that management confidence is improving.
On the fundamentals side, earnings per share are accelerating and the forward PE is notably lower than the current level, suggesting earnings growth ahead. Revenue is expanding at a robust pace, outpacing the broader banking sector. Profitability metrics such as operating margin and return on equity are healthy for a regional bank. The company pays a dividend that yields well above the average for its industry, and the payout ratio remains modest, indicating sustainability. Valuation models place intrinsic value substantially above the market price, implying an upside potential in the mid‑teens. Combined with a low beta and a solid balance sheet, the risk‑adjusted profile appears attractive for investors seeking both growth and income.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • bullish technical indicators
  • insider buying activity
  • attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to intrinsic value
  • strong revenue growth
  • solid profitability margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend
  • low beta and defensive profile
  • long‑term earnings expansion

Key Metrics & Analysis

Financial Health

Revenue Growth32.40%
Profit Margin32.72%
P/E Ratio11.2
ROE14.22%
ROA1.68%
P/B Ratio1.4
Op. Cash Flow$23.5M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI59.2
Support$50.20
Resistance$53.97
MA 20$51.67
MA 50$50.65
MA 200$46.49
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$68.54
Target Price$60.33
Upside/Downside14.57%
GradeUndervalued
TypeBlend
Dividend Yield2.51%

Risk Assessment

Beta0.77
Volatility15.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.